Q-omics provides the consensus-scored EEF1GP6 profile across patient tissues and cancer cell-line models. EEF1GP6 expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in BRCA. Additionally, EEF1GP6 RNA expression shows 6,161 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight BRCA, and STAD as cancer lineages where EEF1GP6 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.